Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health Inc (NYSE: EVH) delivers transformative healthcare solutions through value-based care models and AI-powered technology. This news hub provides investors and healthcare professionals with essential updates on the company developments shaping modern care delivery.
Access authoritative coverage of EVH's strategic initiatives including specialty care management advancements, AI-driven clinical review systems, and partnerships with major health systems. Our curated news collection features earnings reports, regulatory filings, and analysis of operational milestones in oncology, cardiology, and musculoskeletal care management.
Key focus areas include updates on Evolent's proprietary platforms for total cost of care optimization, health plan administration innovations, and value-based payment model expansions. Stay informed about technological integrations like the Machinify Auth AI system that streamline clinical decision-making processes.
Bookmark this page for real-time updates on EVH's progress in aligning financial incentives with patient outcomes. Monitor how their integrated approach to population health management continues to redefine care delivery standards across healthcare networks.
Evolent Health (NYSE: EVH) reported its Q3 2020 results with a revenue of $264.6 million, marking a 20.2% year-over-year increase. Despite the revenue growth, the company faced a net loss of $(37.3) million. Adjusted EBITDA improved to $12.7 million from $3.3 million in Q3 2019. The company announced new partnerships and completed the Passport Health Plan asset sale, enhancing operational efficiencies. Evolent has a cash position of $387 million as of September 30, 2020, and aims to optimize capital allocation for long-term shareholder value.
Evolent Health (NYSE: EVH) will release its third quarter 2020 operating results on November 5, 2020, after market close. Following the release, a conference call will be held at 5:00 p.m. Eastern Time. Investors can join the call by dialing 855.940.9467 or 412.317.6034 for international participants. The call will include details about Evolent's clinical and administrative solutions aimed at enhancing health care affordability and quality. An audio replay will be available on Evolent's investor relations website for one week post-call.
Evolent Health (NYSE: EVH) hosted a virtual Investor and Analyst Day on September 29, 2020, presenting its strategy to enhance shareholder value and operational updates. The Company targets approximately 30% year-over-year adjusted services revenue growth for 2020 and aims for mid-teens annual growth in the medium term. Key announcements include partnerships with Physicians Accountable Care of Utah and Tar River Health Alliance, cost-cutting measures targeting $20-25M in SG&A expenses for 2021, and a focus on achieving a mid-teens Adjusted EBITDA margin. Adjusted Revenue guidance for Q3 2020 is set between $258M-272M.
Evolent Health (NYSE: EVH) will hold its annual Investor and Analyst Day on September 29, 2020, from 10:00 a.m. ET to 12:30 p.m. ET virtually. Interested participants can register and find the live webcast on the company's investor relations website. A replay will also be available post-event. Evolent Health specializes in clinical and administrative solutions to enhance health care affordability and simplicity, serving a diverse range of payers and providers nationwide. The company is recognized for its innovative approaches and quality health solutions.
Evolent Health (NYSE: EVH) will have its CEO Frank Williams, President Seth Blackley, and CFO John Johnson participate in the Baird 2020 Global Healthcare Conference on September 10, 2020, at 9:05 a.m. ET. A live webcast can be accessed through the investor relations section of Evolent's website. Evolent Health specializes in clinical and administrative solutions aimed at improving healthcare quality and affordability, serving a broad base of payers and providers. The company is recognized for its population health program accreditation.
Evolent Health (NYSE: EVH) announced that CEO Frank Williams, President Seth Blackley, and CFO John Johnson will present at two upcoming investor conferences. The presentations will take place at the Wells Fargo 2020 Virtual Healthcare Conference on September 9, 2020, at 10:40 a.m. ET and at the Baird 2020 Global Healthcare Conference on September 10, 2020, at 9:05 a.m. ET. Evolent Health specializes in health care solutions that improve health affordability and management, serving a national base of leading payers and providers.
Evolent Health (NYSE: EVH) announced a significant financial maneuver involving the issuance of $117 million principal amount of 3.50% Convertible Senior Notes due 2024. This issuance includes $84.2 million in exchange for existing 2.00% Convertible Senior Notes due 2021, alongside $32.8 million generated through cash subscriptions. Expected net proceeds are estimated at $27.4 million. Following this transaction, $26.7 million of the 2021 Notes will remain outstanding. The new notes will be convertible into cash or Evolent's Class A common stock at an initial price of approximately $18.23 per share, representing a 30% premium over the stock's closing price on August 13, 2020.
Evolent Health (EVH) reported a 24.3% increase in GAAP revenue, reaching $238.6 million for Q2 2020 compared to Q2 2019. Despite this growth, the company recorded a net loss of $(203.5) million, impacted by a non-cash goodwill impairment of $215.1 million. Adjusted EBITDA stood at $9.0 million, showcasing operational improvements. Evolent also added two new partners and anticipates over 30% revenue growth in its Services business for the year, alongside a focus on margin enhancement. There will be a change in leadership with Seth Blackley being promoted to CEO on October 1, 2020.
Evolent Health, a healthcare company listed on NYSE as EVH, announced its participation in the 40th Annual Canaccord Genuity Growth Conference. CEO Frank Williams, President Seth Blackley, and CFO John Johnson will present on August 13, 2020, at 10:30 a.m. ET. A live webcast will be available on Evolent's investor relations website. Evolent Health is known for its clinical and administrative solutions that enhance healthcare affordability and quality, holding the first NCQA Population Health Program Accreditation.
Evolent Health (NYSE: EVH) reported significant findings in the July issue of The American Journal of Managed Care, indicating that remote health advising and care management interventions can markedly decrease hospitalizations and medical spending for high-risk Medicare beneficiaries. The study revealed that participating patients had a 21% reduction in inpatient admissions and a 22% decrease in total medical costs. Those deeply engaged in the program experienced even greater benefits, with 47% fewer readmissions and a 42% reduction in medical spending. The analysis followed nearly 1,900 high-risk participants over six months.
